1 Study Coverage 1.1 Conjugate Vaccine Product Introduction 1.2 Market by Type 1.2.1 Global Conjugate Vaccine Market Size Growth Rate by Type 1.2.2 Hib Vaccine 1.2.3 Meningococcal Vaccine 1.2.4 Pneumococcal Vaccine 1.2.5 Others 1.3 Market by End Users 1.3.1 Global Conjugate Vaccine Market Size Growth Rate by End Users 1.3.2 Children 1.3.3 Adult 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Conjugate Vaccine Market Size, Estimates and Forecasts 2.1.1 Global Conjugate Vaccine Revenue 2016-2027 2.1.2 Global Conjugate Vaccine Sales 2016-2027 2.2 Global Conjugate Vaccine, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Conjugate Vaccine Historical Market Size by Region (2016-2021) 2.3.1 Global Conjugate Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Conjugate Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Conjugate Vaccine Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Conjugate Vaccine Sales Forecast by Region (2022-2027) 2.4.2 Global Conjugate Vaccine Revenue Forecast by Region (2022-2027) 3 Global Conjugate Vaccine Competitor Landscape by Players 3.1 Global Top Conjugate Vaccine Manufacturers by Sales 3.1.1 Global Conjugate Vaccine Sales by Manufacturer (2016-2021) 3.1.2 Global Conjugate Vaccine Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Conjugate Vaccine Manufacturers by Revenue 3.2.1 Key Conjugate Vaccine Manufacturers Covered: Ranking by Revenue 3.2.2 Global Conjugate Vaccine Revenue by Manufacturers (2016-2021) 3.2.3 Global Conjugate Vaccine Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Conjugate Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Conjugate Vaccine Revenue in 2020 3.2.6 Global Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Conjugate Vaccine Price by Manufacturers 3.4 Global Conjugate Vaccine Manufacturing Base Distribution, Product Types 3.4.1 Conjugate Vaccine Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Conjugate Vaccine Product Type 3.4.3 Date of International Manufacturers Enter into Conjugate Vaccine Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Conjugate Vaccine Market Size by Type (2016-2021) 4.1.1 Global Conjugate Vaccine Sales by Type (2016-2021) 4.1.2 Global Conjugate Vaccine Revenue by Type (2016-2021) 4.1.3 Conjugate Vaccine Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Conjugate Vaccine Market Size Forecast by Type (2022-2027) 4.2.1 Global Conjugate Vaccine Sales Forecast by Type (2022-2027) 4.2.2 Global Conjugate Vaccine Revenue Forecast by Type (2022-2027) 4.2.3 Conjugate Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by End Users (2016-2027) 5.1 Global Conjugate Vaccine Market Size by End Users (2016-2021) 5.1.1 Global Conjugate Vaccine Sales by End Users (2016-2021) 5.1.2 Global Conjugate Vaccine Revenue by End Users (2016-2021) 5.1.3 Conjugate Vaccine Price by End Users (2016-2021) 5.2 Conjugate Vaccine Market Size Forecast by End Users (2022-2027) 5.2.1 Global Conjugate Vaccine Sales Forecast by End Users (2022-2027) 5.2.2 Global Conjugate Vaccine Revenue Forecast by End Users (2022-2027) 5.2.3 Global Conjugate Vaccine Price Forecast by End Users (2022-2027) 6 Japan by Players, Type and End Users 6.1 Japan Conjugate Vaccine Market Size YoY Growth 2016-2027 6.1.1 Japan Conjugate Vaccine Sales YoY Growth 2016-2027 6.1.2 Japan Conjugate Vaccine Revenue YoY Growth 2016-2027 6.1.3 Japan Conjugate Vaccine Market Share in Global Market 2016-2027 6.2 Japan Conjugate Vaccine Market Size by Players (International and Local Players) 6.2.1 Japan Top Conjugate Vaccine Players by Sales (2016-2021) 6.2.2 Japan Top Conjugate Vaccine Players by Revenue (2016-2021) 6.3 Japan Conjugate Vaccine Historic Market Review by Type (2016-2021) 6.3.1 Japan Conjugate Vaccine Sales Market Share by Type (2016-2021) 6.3.2 Japan Conjugate Vaccine Revenue Market Share by Type (2016-2021) 6.3.3 Japan Conjugate Vaccine Price by Type (2016-2021) 6.4 Japan Conjugate Vaccine Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Conjugate Vaccine Sales Forecast by Type (2022-2027) 6.4.2 Japan Conjugate Vaccine Revenue Forecast by Type (2022-2027) 6.4.3 Japan Conjugate Vaccine Price Forecast by Type (2022-2027) 6.5 Japan Conjugate Vaccine Historic Market Review by End Users (2016-2021) 6.5.1 Japan Conjugate Vaccine Sales Market Share by End Users (2016-2021) 6.5.2 Japan Conjugate Vaccine Revenue Market Share by End Users (2016-2021) 6.5.3 Japan Conjugate Vaccine Price by End Users (2016-2021) 6.6 Japan Conjugate Vaccine Market Estimates and Forecasts by End Users (2022-2027) 6.6.1 Japan Conjugate Vaccine Sales Forecast by End Users (2022-2027) 6.6.2 Japan Conjugate Vaccine Revenue Forecast by End Users (2022-2027) 6.6.3 Japan Conjugate Vaccine Price Forecast by End Users (2022-2027) 7 North America 7.1 North America Conjugate Vaccine Market Size YoY Growth 2016-2027 7.2 North America Conjugate Vaccine Market Facts & Figures by Country 7.2.1 North America Conjugate Vaccine Sales by Country (2016-2021) 7.2.2 North America Conjugate Vaccine Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Conjugate Vaccine Market Size YoY Growth 2016-2027 8.2 Asia Pacific Conjugate Vaccine Market Facts & Figures by Region 8.2.1 Asia Pacific Conjugate Vaccine Sales by Region (2016-2021) 8.2.2 Asia Pacific Conjugate Vaccine Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Conjugate Vaccine Market Size YoY Growth 2016-2027 9.2 Europe Conjugate Vaccine Market Facts & Figures by Country 9.2.1 Europe Conjugate Vaccine Sales by Country (2016-2021) 9.2.2 Europe Conjugate Vaccine Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Conjugate Vaccine Market Size YoY Growth 2016-2027 10.2 Latin America Conjugate Vaccine Market Facts & Figures by Country 10.2.1 Latin America Conjugate Vaccine Sales by Country (2016-2021) 10.2.2 Latin America Conjugate Vaccine Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Conjugate Vaccine Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Conjugate Vaccine Market Facts & Figures by Country 11.2.1 Middle East and Africa Conjugate Vaccine Sales by Country (2016-2021) 11.2.2 Middle East and Africa Conjugate Vaccine Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Pfizer 12.1.1 Pfizer Corporation Information 12.1.2 Pfizer Description and Business Overview 12.1.3 Pfizer Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Pfizer Conjugate Vaccine Products Offered 12.1.5 Pfizer Recent Development 12.2 GSK 12.2.1 GSK Corporation Information 12.2.2 GSK Description and Business Overview 12.2.3 GSK Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.2.4 GSK Conjugate Vaccine Products Offered 12.2.5 GSK Recent Development 12.3 Sanofi 12.3.1 Sanofi Corporation Information 12.3.2 Sanofi Description and Business Overview 12.3.3 Sanofi Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Sanofi Conjugate Vaccine Products Offered 12.3.5 Sanofi Recent Development 12.4 Merck 12.4.1 Merck Corporation Information 12.4.2 Merck Description and Business Overview 12.4.3 Merck Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Merck Conjugate Vaccine Products Offered 12.4.5 Merck Recent Development 12.5 Walvax Biotechnology 12.5.1 Walvax Biotechnology Corporation Information 12.5.2 Walvax Biotechnology Description and Business Overview 12.5.3 Walvax Biotechnology Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Walvax Biotechnology Conjugate Vaccine Products Offered 12.5.5 Walvax Biotechnology Recent Development 12.6 Royal (Wuxi) Bio-Pharmaceutical 12.6.1 Royal (Wuxi) Bio-Pharmaceutical Corporation Information 12.6.2 Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview 12.6.3 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Products Offered 12.6.5 Royal (Wuxi) Bio-Pharmaceutical Recent Development 12.7 Bharat Biotech 12.7.1 Bharat Biotech Corporation Information 12.7.2 Bharat Biotech Description and Business Overview 12.7.3 Bharat Biotech Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Bharat Biotech Conjugate Vaccine Products Offered 12.7.5 Bharat Biotech Recent Development 12.8 Zhifei Biologic 12.8.1 Zhifei Biologic Corporation Information 12.8.2 Zhifei Biologic Description and Business Overview 12.8.3 Zhifei Biologic Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Zhifei Biologic Conjugate Vaccine Products Offered 12.8.5 Zhifei Biologic Recent Development 12.11 Pfizer 12.11.1 Pfizer Corporation Information 12.11.2 Pfizer Description and Business Overview 12.11.3 Pfizer Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Pfizer Conjugate Vaccine Products Offered 12.11.5 Pfizer Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Conjugate Vaccine Industry Trends 13.2 Conjugate Vaccine Market Drivers 13.3 Conjugate Vaccine Market Challenges 13.4 Conjugate Vaccine Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Conjugate Vaccine Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Conjugate Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Hib Vaccine Table 3. Major Manufacturers of Meningococcal Vaccine Table 4. Major Manufacturers of Pneumococcal Vaccine Table 5. Major Manufacturers of Others Table 6. Global Conjugate Vaccine Market Size Growth Rate by End Users (2021-2027) & (Million Unit) Table 7. Global Conjugate Vaccine Market Size by Region (Million Unit) & (US$ Million), 2016 VS 2021 VS 2027 Table 8. Global Conjugate Vaccine Sales by Regions (2016-2021) & (Million Unit) Table 9. Global Conjugate Vaccine Sales Market Share by Regions (2016-2021) Table 10. Global Conjugate Vaccine Revenue by Regions (2016-2021) & (US$ Million) Table 11. Global Conjugate Vaccine Sales Forecast by Region (2022-2027) & (Million Unit) Table 12. Global Conjugate Vaccine Sales Market Share Forecast by Region (2022-2027) Table 13. Global Conjugate Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million) Table 14. Global Conjugate Vaccine Revenue Market Share Forecast by Region (2022-2027) Table 15. Global Conjugate Vaccine Sales by Manufacturers (2016-2021) (Million Unit) Table 16. Global Conjugate Vaccine Sales Share by Manufacturers (2016-2021) Table 17. Ranking of Global Top Conjugate Vaccine Manufacturers by Revenue (US$ Million) in 2020 Table 18. Conjugate Vaccine Revenue by Manufacturers (2016-2021) (US$ Million) Table 19. Conjugate Vaccine Revenue Share by Manufacturers (2016-2021) Table 20. Global Conjugate Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 21. Global Conjugate Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Conjugate Vaccine as of 2020) Table 22. Key Manufacturers Conjugate Vaccine Price (2016-2021) (USD/Unit) Table 23. Conjugate Vaccine Manufacturers Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Conjugate Vaccine Product Type Table 25. Date of International Manufacturers Enter into Conjugate Vaccine Market Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans Table 27. Global Conjugate Vaccine Sales by Type (2016-2021) (Million Unit) Table 28. Global Conjugate Vaccine Sales Share by Type (2016-2021) Table 29. Global Conjugate Vaccine Revenue by Type (2016-2021) (US$ Million) Table 30. Global Conjugate Vaccine Revenue Share by Type (2016-2021) Table 31. Conjugate Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit) Table 32. Global Conjugate Vaccine Sales Forecast by Type (2022-2027) & (Million Unit) Table 33. Global Conjugate Vaccine Sales Market Share Forecast by Type (2022-2027) Table 34. Global Conjugate Vaccine Revenue Forecast V (2022-2027) & (US$ Million) Table 35. Global Conjugate Vaccine Revenue Market Share Forecast by Type (2022-2027) Table 36. Global Conjugate Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit) Table 37. Global Conjugate Vaccine Sales by End Users (2016-2021) (Million Unit) Table 38. Global Conjugate Vaccine Sales Share by End Users (2016-2021) Table 39. Global Conjugate Vaccine Revenue by End Users (2016-2021) (US$ Million) Table 40. Global Conjugate Vaccine Revenue Share by End Users (2016-2021) Table 41. Conjugate Vaccine Average Selling Price (ASP) by End Users (2016-2021) & (USD/Unit) Table 42. Global Conjugate Vaccine Sales Forecast by End Users (2022-2027) & (Million Unit) Table 43. Global Conjugate Vaccine Sales Market Share Forecast by End Users (2022-2027) Table 44. Global Conjugate Vaccine Revenue Forecast by End Users (2022-2027) & (US$ Million) Table 45. Global Conjugate Vaccine Revenue Market Share Forecast by End Users (2022-2027) Table 46. Global Conjugate Vaccine Average Selling Price (ASP) Forecast by End Users (2022-2027) & (USD/Unit) Table 47. Japan Conjugate Vaccine Sales (Million Unit) of Key Companies (2016-2021) Table 48. Japan Conjugate Vaccine Sales Share by Company (2016-2021) Table 49. Japan Conjugate Vaccine Revenue (US$ Million) by Company (2016-2021) Table 50. Japan Conjugate Vaccine Revenue Share by Company (2016-2021) Table 51. Japan Conjugate Vaccine Sales (Million Unit) by Type (2016-2021) Table 52. Japan Conjugate Vaccine Sales Share by Type (2016-2021) Table 53. Japan Conjugate Vaccine Revenue (US$ Million) Market Share by Type (2016-2021) Table 54. Japan Conjugate Vaccine Price (USD/Unit) by Type (2016-2021) Table 55. Japan Conjugate Vaccine Sales (Million Unit) by Type (2022-2027) Table 56. Japan Conjugate Vaccine Sales Share by Type (2022-2027) Table 57. Japan Conjugate Vaccine Revenue (US$ Million) Market Share by Type (2022-2027) Table 58. Japan Conjugate Vaccine Revenue Share by Type (2022-2027) Table 59. Japan Conjugate Vaccine Price (USD/Unit) by Type (2022-2027) Table 60. Japan Conjugate Vaccine Sales (Million Unit) by End Users (2016-2021) Table 61. Japan Conjugate Vaccine Sales Share by End Users (2016-2021) Table 62. Japan Conjugate Vaccine Revenue (US$ Million) Market Share by End Users (2016-2021) Table 63. Japan Conjugate Vaccine Price (USD/Unit) by End Users (2016-2021) Table 64. Japan Conjugate Vaccine Sales (Million Unit) by End Users (2022-2027) Table 65. Japan Conjugate Vaccine Sales Share by End Users (2022-2027) Table 66. Japan Conjugate Vaccine Revenue (US$ Million) Market Share by End Users (2022-2027) Table 67. Japan Conjugate Vaccine Revenue Share by End Users (2022-2027) Table 68. Japan Conjugate Vaccine Price (USD/Unit) by End Users (2022-2027) Table 69. North America Conjugate Vaccine Sales by Country (2016-2021) & (Million Unit) Table 70. North America Conjugate Vaccine Sales Market Share by Country (2016-2021) Table 71. North America Conjugate Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 72. North America Conjugate Vaccine Revenue Market Share by Country (2016-2021) Table 73. Asia Pacific Conjugate Vaccine Sales by Region (2016-2021) & (Million Unit) Table 74. Asia Pacific Conjugate Vaccine Sales Market Share by Region (2016-2021) Table 75. Asia Pacific Conjugate Vaccine Revenue by Region (2016-2021) & (US$ Million) Table 76. Asia Pacific Conjugate Vaccine Revenue Market Share by Region (2016-2021) Table 77. Europe Conjugate Vaccine Sales by Country (2016-2021) & (Million Unit) Table 78. Europe Conjugate Vaccine Sales Market Share by Country (2016-2021) Table 79. Europe Conjugate Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 80. Europe Conjugate Vaccine Revenue Market Share by Country (2016-2021) Table 81. Latin America Conjugate Vaccine Sales by Country (2016-2021) & (Million Unit) Table 82. Latin America Conjugate Vaccine Sales Market Share by Country (2016-2021) Table 83. Latin Americaa Conjugate Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 84. Latin America Conjugate Vaccine Revenue Market Share by Country (2016-2021) Table 85. Middle East and Africa Conjugate Vaccine Sales by Country (2016-2021) & (Million Unit) Table 86. Middle East and Africa Conjugate Vaccine Sales Market Share by Country (2016-2021) Table 87. Middle East and Africa Conjugate Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 88. Middle East and Africa Conjugate Vaccine Revenue Market Share by Country (2016-2021) Table 89. Pfizer Corporation Information Table 90. Pfizer Description and Business Overview Table 91. Pfizer Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 92. Pfizer Conjugate Vaccine Product Table 93. Pfizer Recent Development Table 94. GSK Corporation Information Table 95. GSK Description and Business Overview Table 96. GSK Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 97. GSK Product Table 98. GSK Recent Development Table 99. Sanofi Corporation Information Table 100. Sanofi Description and Business Overview Table 101. Sanofi Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 102. Sanofi Product Table 103. Sanofi Recent Development Table 104. Merck Corporation Information Table 105. Merck Description and Business Overview Table 106. Merck Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 107. Merck Product Table 108. Merck Recent Development Table 109. Walvax Biotechnology Corporation Information Table 110. Walvax Biotechnology Description and Business Overview Table 111. Walvax Biotechnology Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 112. Walvax Biotechnology Product Table 113. Walvax Biotechnology Recent Development Table 114. Royal (Wuxi) Bio-Pharmaceutical Corporation Information Table 115. Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview Table 116. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 117. Royal (Wuxi) Bio-Pharmaceutical Product Table 118. Royal (Wuxi) Bio-Pharmaceutical Recent Development Table 119. Bharat Biotech Corporation Information Table 120. Bharat Biotech Description and Business Overview Table 121. Bharat Biotech Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 122. Bharat Biotech Product Table 123. Bharat Biotech Recent Development Table 124. Zhifei Biologic Corporation Information Table 125. Zhifei Biologic Description and Business Overview Table 126. Zhifei Biologic Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 127. Zhifei Biologic Product Table 128. Zhifei Biologic Recent Development Table 129. Conjugate Vaccine Market Trends Table 130. Conjugate Vaccine Market Drivers Table 131. Conjugate Vaccine Market Challenges Table 132. Conjugate Vaccine Market Restraints Table 133. Conjugate Vaccine Customers List Table 134. Conjugate Vaccine Distributors List Table 135. Research Programs/Design for This Report Table 136. Key Data Information from Secondary Sources Table 137. Key Data Information from Primary Sources List of Figures Figure 1. Conjugate Vaccine Product Picture Figure 2. Global Conjugate Vaccine Sales Market Share by Type in 2020 & 2027 Figure 3. Hib Vaccine Product Picture Figure 4. Meningococcal Vaccine Product Picture Figure 5. Pneumococcal Vaccine Product Picture Figure 6. Others Product Picture Figure 7. Global Conjugate Vaccine Sales Market Share by End Users in 2020 & 2027 Figure 8. Children Figure 9. Adult Figure 10. Conjugate Vaccine Report Years Considered Figure 11. Global Conjugate Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Conjugate Vaccine Market Size 2016-2027 (US$ Million) Figure 13. Global Conjugate Vaccine Sales 2016-2027 (Million Unit) Figure 14. Global Conjugate Vaccine Market Size Market Share by Region: 2021 Versus 2027 Figure 15. Global Conjugate Vaccine Sales Market Share by Region (2016-2021) Figure 16. Global Conjugate Vaccine Sales Market Share by Region in 2020 Figure 17. Global Conjugate Vaccine Revenue Market Share by Region (2016-2021) Figure 18. Global Conjugate Vaccine Revenue Market Share by Region in 2020 Figure 19. Global Conjugate Vaccine Sales Share by Manufacturer in 2020 Figure 20. The Top 10 and 5 Players Market Share by Conjugate Vaccine Revenue in 2020 Figure 21. Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 22. Global Conjugate Vaccine Sales Market Share by Type (2016-2021) Figure 23. Global Conjugate Vaccine Sales Market Share by Type in 2020 Figure 24. Global Conjugate Vaccine Revenue Market Share by Type (2016-2021) Figure 25. Global Conjugate Vaccine Revenue Market Share by Type in 2020 Figure 26. Global Conjugate Vaccine Sales Market Share by End Users (2016-2021) Figure 27. Global Conjugate Vaccine Sales Market Share by End Users in 2020 Figure 28. Global Conjugate Vaccine Revenue Market Share by End Users (2016-2021) Figure 29. Global Conjugate Vaccine Revenue Market Share by End Users in 2020 Figure 30. Japan Conjugate Vaccine Sales Growth Rate 2016-2027 (Million Unit) Figure 31. Japan Conjugate Vaccine Revenue Growth Rate 2016-2027 (US$ Million) Figure 32. Japan Conjugate Vaccine Market Share in Global Market 2016-2027 Figure 33. Japan 5 and 10 Largest Conjugate Vaccine Players Market Share by Revenue in Conjugate Vaccine in 2020 Figure 34. Japan Conjugate Vaccine Revenue Share by Type (2016-2021) Figure 35. Japan Conjugate Vaccine Revenue Growth Rate by Type in 2016 & 2020 Figure 36. Japan Conjugate Vaccine Revenue Share by End Users (2016-2021) Figure 37. Japan Conjugate Vaccine Revenue Growth Rate by End Users in 2016 & 2020 Figure 38. North America Conjugate Vaccine Sales Growth Rate 2016-2021 (Million Unit) Figure 39. North America Conjugate Vaccine Revenue Growth Rate 2016-2021 (US$ Million) Figure 40. North America Conjugate Vaccine Sales Market Share by Country in 2020 Figure 41. North America Conjugate Vaccine Revenue Market Share by Country in 2020 Figure 42. U.S. Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 43. U.S. Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Canada Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 45. Canada Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Europe Conjugate Vaccine Sales Growth Rate 2016-2021 (Million Unit) Figure 47. Europe Conjugate Vaccine Revenue Growth Rate 2016-2021 (US$ Million) Figure 48. Europe Conjugate Vaccine Sales Market Share by Country in 2020 Figure 49. Europe Conjugate Vaccine Revenue Market Share by Country in 2020 Figure 50. Germany Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 51. Germany Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 52. France Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 53. France Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. U.K. Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 55. U.K. Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. Italy Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 57. Italy Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. Russia Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 59. Russia Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 60. Asia Pacific Conjugate Vaccine Sales Growth Rate 2016-2021 (Million Unit) Figure 61. Asia Pacific Conjugate Vaccine Revenue Growth Rate 2016-2021 (US$ Million) Figure 62. Asia Pacific Conjugate Vaccine Sales Market Share by Region in 2020 Figure 63. Asia Pacific Conjugate Vaccine Revenue Market Share by Region in 2020 Figure 64. China Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 65. China Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 66. Japan Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 67. Japan Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 68. South Korea Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 69. South Korea Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. India Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 71. India Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. Australia Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 73. Australia Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. Taiwan Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 75. Taiwan Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. Indonesia Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 77. Indonesia Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Thailand Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 79. Thailand Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Malaysia Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 81. Malaysia Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 82. Philippines Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 83. Philippines Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 84. Vietnam Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 85. Vietnam Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 86. Latin America Conjugate Vaccine Sales Growth Rate 2016-2021 (Million Unit) Figure 87. Latin America Conjugate Vaccine Revenue Growth Rate 2016-2021 (US$ Million) Figure 88. Latin America Conjugate Vaccine Sales Market Share by Country in 2020 Figure 89. Latin America Conjugate Vaccine Revenue Market Share by Country in 2020 Figure 90. Mexico Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 91. Mexico Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 92. Brazil Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 93. Brazil Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 94. Argentina Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 95. Argentina Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 96. Middle East and Africa Conjugate Vaccine Sales Growth Rate 2016-2021 (Million Unit) Figure 97. Middle East and Africa Conjugate Vaccine Revenue Growth Rate 2016-2021 (US$ Million) Figure 98. Middle East and Africa Conjugate Vaccine Sales Market Share by Country in 2020 Figure 99. Middle East and Africa Conjugate Vaccine Revenue Market Share by Country in 2020 Figure 100. Turkey Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 101. Turkey Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 102. Saudi Arabia Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 103. Saudi Arabia Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 104. UAE Conjugate Vaccine Sales Growth Rate (2016-2021) (Million Unit) Figure 105. UAE Conjugate Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 106. Conjugate Vaccine Value Chain Figure 107. Channels of Distribution Figure 108. Distributors Profiles Figure 109. Bottom-up and Top-down Approaches for This Report Figure 110. Data Triangulation Figure 111. Key Executives Interviewed

Pfizer GSK Sanofi Merck Walvax Biotechnology Royal (Wuxi) Bio-Pharmaceutical Bharat Biotech Zhifei Biologic